 This study tested whether simultaneous administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine produces immunogenicity in older individuals and found that it is comparable to sequential administration without an increase in adverse reactions. This article was authored by K. Nakashima, Masahiro Ayashima, Satoko Ofuji, and others.